DisclosureWe earn commission on partner links; ranking is set by clinician-vetted methodology — not advertisers.
Reseñas independientes de cada medicamento GLP-1, proveedor de telemedicina y programa de pérdida de peso — revisado médicamente y actualizado mensualmente.

Obesity-medicine telehealth that takes insurance

Eli Lilly oral tirzepatide for weight loss (Apr 2026 launch)

Telehealth GLP-1 with brand-name and compounded options

First FDA-approved oral semaglutide for weight loss (Jan 2026)

Compounded semaglutide via telehealth